- Spain CIMA (Spanish): search for “glucosa” (external search; text not reproduced)
External search; text not reproduced. Check the Philippine package insert in the products table.
Dosing: Altered kidney function
No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.
Kidney-specific guidance from renalcarematters.com: in preparation.
Dosage forms
Philippines
- ) solution for iv injection: 500 mg/mL (10 g/20 mL
- Solution for iv infusion: 5 mg/100 mL
Registered products in the Philippines
2 products registered with the Food and Drug Administration (FDA) Philippines list Glucose as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.
| Package insert | |||||||
|---|---|---|---|---|---|---|---|
Axadex D5Glucose (as monohydrate) | 5mg/100mL (5% w/v) Solution for IV InfusionLDPE Bottle with white translucent polyethylene cap and grey bromobutyl rubber disc x 1L | Rx | Axa Parenterals Limited.India | S.M.H.P. Marketing & Consultancy | DRP-14063 | Jun 9, 2028 | |
NoneGlucose | 500 mg/mL (10 g/20 mL) Solution for IV InjectionLDPE Plastic FFS Ampoule x 20mL (Box of 6's) | Rx | Zhejiang Tianrui Pharmaceutical Co., Ltd.China | Global Pharmatrade | DR-XY42523 | Sep 3, 2028 |
Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.
Formulary and pricing (Philippines)
Government price references
| Preparation | Price (PHP) | Unit | Type |
|---|---|---|---|
| Glucose (Dextrose) 50%, 50 mL Vial | ₱19.60–₱78.89Reference ₱19.60 | per vial | DPRI procurement range |
Range = lowest-highest procurement price (highest usable only in GIDA areas); reference_price = 2021 DPRI ceiling (median)
These are government procurement and reimbursement references, not retail prices. Sources:
- DOH Drug Price Reference Index (DPRI) 2021, 9th edition (as of September 17, 2021); https://caro.doh.gov.ph/wp-content/uploads/2021/09/2021DPRI-as-of-9-17-2021.pdf, as of September 17, 2021
Formulary and coverage
| Philippine National Formulary | Listed as Glucose (dextrose) |
| PNF listing | Inj.: 50%, 50 mL vial (IV) |
| PNF listing | Inj.: 50%, 10 mL and 20 mL ampul (IV) |
| PNF listing | Inj.: 50%, 10 mL, 20 mL and 50 mL (85 Kcal) vial (IV) |
| PhilHealth GAMOT | No |
Sources:
- PNF Essential Medicines List, 8th ed. (as of November 2, 2022), DOH; https://www.philhealth.gov.ph/partners/providers/pdf/PNF-EML_11022022.pdf, as of November 2, 2022
Check availability
Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.
References
- Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph
- PNF Essential Medicines List, 8th ed. (as of November 2, 2022), DOH; https://www.philhealth.gov.ph/partners/providers/pdf/PNF-EML_11022022.pdf
- DOH Drug Price Reference Index (DPRI) 2021, 9th edition (as of September 17, 2021); https://caro.doh.gov.ph/wp-content/uploads/2021/09/2021DPRI-as-of-9-17-2021.pdf
This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.
Last updated: .